Wouter W. de Herder

Based at Erasmus University Rotterdam, Wouter W. de Herder focuses their scholarly efforts on neuroendocrine tumors, neuroblastoma, lung cancer, somatostatin analogues, clinical trial design, gastroenteropancreatic NETs, endocrine oncology, translational medicine, bridging the gap between theory and practice in neuroendocrine tumors. A representative example of their recent contribution is the study titled "Consensus report on the use of somatostatin analogs for the management of neuroendocrine tumors of the gastroenteropancreatic system", which offers critical insights into the dynamics of neuroendocrine tumors and neuroblastoma. Additional work such as "Combined therapy with somatostatin analogues and weekly pegvisomant in active acromegaly" further demonstrates their commitment to advancing knowledge in this domain.